MedPath

OGIVRI 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

OGIVRI 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1181341001

Prescription Type

Uso Hospitalario

Authorization Date

Feb 28, 2019

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181341001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
Yes
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TRASTUZUMABActive
Quantity: 150 mg
Name: TRASTUZUMAB

ATC CLASSIFICATION (3)

L01F
L01FD
L01FD01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.